Stock UTHR UNITED THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News United Therapeutics Corporation

Equities

UTHR

US91307C1027

Real-time Estimate Cboe BZX
Other stock markets
 01:51:31 2024-04-18 pm EDT 		5-day change 1st Jan Change
238 USD +1.16% Intraday chart for United Therapeutics Corporation +0.08% +7.97%
Apr. 17 United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing MT
Apr. 15 United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing
MT
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
BU
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing
MT
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension
MT
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling
DJ
United Therapeutics Corporation Announces Extension of Credit Agreement
CI
United Therapeutics Insider Sold Shares Worth $7,375,339, According to a Recent SEC Filing
MT
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
BU
United Therapeutics Corporation announces an Equity Buyback for $1,000 million worth of its shares.
CI
United Therapeutics Insider Sold Shares Worth $7,100,981, According to a Recent SEC Filing
MT
United Therapeutics Authorizes Accelerated $1 Billion Stock Buyback Through Citigroup
MT
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
BU
United Therapeutics Corporation authorizes a Buyback Plan.
CI
United Therapeutics Insider Sold Shares Worth $1,418,726, According to a Recent SEC Filing
MT
United Therapeutics Insider Sold Shares Worth $7,088,196, According to a Recent SEC Filing
MT
The Printed Future Of Transplantology, Or How Science Fiction Became Reality
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. UTHR Stock
  4. News United Therapeutics Corporation